Last reviewed · How we verify

NCT06681857

Maxillary Sinus Floor Elevation With Gelatin Sponge Versus Allogenic Demineralized Bone Matrix

Completed NA Last updated 10 September 2025
What this trial tests

NA trial testing Sinus lifting in Maxillary Sinus Disease in 14 participants. Completed in 9 September 2025.

Timeline
1 December 2024
Primary endpoint
1 September 2025
9 September 2025

Quick facts

Lead sponsorBeni-Suef University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment14
Start date1 December 2024
Primary completion1 September 2025
Estimated completion9 September 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 25 to 55, any sex, with Maxillary Sinus Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The post-extraction pneumatization of the maxillary sinus often compromises the ability of the maxillary molar to the optimal recipient of dental implants as a consequence of the quantitative reduction of the vertical bone height and the reduced bone quality of the region posterior maxillary segment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Maxillary Sinus Disease

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06681857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing